F086 Hidradenitis Suppurativa Management in Kids and Teens
DESCRIPTION
Open admission to eligible categories, no tuition or ticket
Hidradenitis suppurativa is increasingly being recognized earlier with more recognition and need for treatment in pediatric and adolescent patients. This session will present the latest, evidence-based management recommendations. The session will explore the management of HS including in children and teens with discussion of clinical findings, comorbidities, and treatment strategies to optimize management.
LEARNING OBJECTIVES
Utilize up-to-date management approaches to treat hidradenitis suppurativa cases pediatric patients
Describe new and emerging medical, surgical, and wound care strategies for hidradenitis suppurativa
Identify challenges in hidradenitis suppurativa evaluation and management and use of first, second, and third line therapies
SCHEDULE
8:00 PM
Introduction
Andrea L. Zaenglein, MD, FAAD, Colleen Cotton, MD, FAAD
8:05 PM
Epidemiology of HS: Now a pediatric disease
Jennifer Ruth, MD, FAAD
8:15 PM
The pathophysiology and genetics of HS
Megan Craddock, MD, FAAD
8:25 PM
Pediatric presentations and HS in special populations
Sadaf Hussain, MD, FAAD
8:35 PM
HS as a systemic disease: Examining pediatric comorbidities
Irene Lara-Corrales, MD, MSc
8:50 PM
Use of biologics in pediatric HS
Jennifer Lin Hsiao, MD, FAAD
9:05 PM
Hormonal treatments and considerations for adolescents with HS
Andrea L. Zaenglein, MD, FAAD
9:15 PM
Other medical treatments for pediatric HS
Vivian Shi, MD, FAAD
9:25 PM
Surgical management of HS: Pediatric considerations
Venessa Pena-Robichaux, MD, FAAD
9:35 PM
Pearls for Treatment of Pediatric HS
Colleen Cotton, MD, FAAD
9:45 PM
Q&A
SPEAKERS
Colleen Cotton, MD, FAAD
Megan Craddock, MD, FAAD
Jennifer Lin Hsiao, MD, FAAD
Sadaf Hussain, MD, FAAD
Irene Lara-Corrales, MD, MSc
Venessa Pena-Robichaux, MD, FAAD
Jennifer Ruth, MD, FAAD
Vivian Shi, MD, FAAD
Andrea L. Zaenglein, MD, FAAD
SPEAKER DISCLOSURES
Colleen Cotton, MD, FAAD
AbbVie – Investigator(Grants/Research Funding); Amgen – Investigator(Grants/Research Funding); Arcutis Biotherapeutics – Investigator(Grants/Research Funding); Eli Lilly and Company – Investigator(Salary); HS Foundation – Board of Directors(No Compensation Received), Investigator(Grants/Research Funding); Inner Archways LLC – Advisory Board(Other Financial Benefit); Janssen Biotech – Advisory Board(Other Financial Benefit); LEO Pharma, US – Advisory Board(Honoraria); Novartis – Other(Other Financial Benefit); Pierre Fabre – Consultant(Honoraria); Regeneron – Investigator(Salary); TARGET Pharma – Investigator(Salary); UCB – Other(Other Financial Benefit);
Megan Craddock, MD, FAAD
No financial relationships exist with ineligible companies.
Jennifer Lin Hsiao, MD, FAAD
AbbVie – Consultant(Fees), Speaker(Fees); Aclaris Therapeutics Inc. – Consultant (1099 relationship)(Fees); Amgen – Investigator(Grants/Research Funding); Boehringer Ingelheim – Consultant(Fees), Investigator(Grants/Research Funding), Speaker(Fees); Galderma – Speaker(Fees); Incyte – Consultant (1099 relationship)(Fees), Investigator(Grants/Research Funding); Novartis – Consultant(Fees), Speaker(Fees); Sanofi – Consultant (1099 relationship)(Fees); Sanofi/Regeneron – Speaker(Fees); UCB – Consultant(Fees), Speaker(Fees);
Sadaf Hussain, MD, FAAD
No financial relationships exist with ineligible companies.
Irene Lara-Corrales, MD, MSc
AbbVie – Consultant(Honoraria), Investigator(Grants/Research Funding); Abeona Therapeutics – Advisory Board(Honoraria); Arcutis Biotherapeutics – Investigator(Grants/Research Funding); Avicanna – Advisory Board(No Compensation Received); Bristol-Myers Squibb – Investigator(Grants/Research Funding); Camp Liberte – Board of Directors(No Compensation Received); Clementia Pharmaceuticals – Investigator(Fees); DeBRA Canada – Board of Directors(No Compensation Received); EB Medical Research Foundation – Investigator(Grants/Research Funding); EB Research Partnership – Investigator(Grants/Research Funding); Eli Lilly – Speaker(Honoraria); Eli Lilly and Company – Investigator(Grants/Research Funding), Speaker(Fees); Ipsen – Advisory Board(Honoraria); La Roche-Posay Laboratorie Pharmaceutique – Investigator(Grants/Research Funding); Mayne Pharma Group – Investigator(Grants/Research Funding); Novartis – Advisory Board(Honoraria); Physicians Services Incorporated (PSI) Foundation – Investigator(Grants/Research Funding); Regeneron – Investigator(Grants/Research Funding); Sanofi Genzyme – Advisory Board(Honoraria), Investigator(Grants/Research Funding); SKin Canada – Investigator(Grants/Research Funding); Timber Pharmaceuticals – Investigator(Grants/Research Funding);
Venessa Pena-Robichaux, MD, FAAD
Osquo – Other(Stock);
Jennifer Ruth, MD, FAAD
No financial relationships exist with ineligible companies.
Vivian Shi, MD, FAAD
AbbVie – Advisory Board(Fees), Speaker(Fees); Alumis – Advisory Board(Honoraria); Aristea Therapeutics – Advisory Board(Fees); Boehringer Ingelheim – Advisory Board(Fees); Burt's Bees – Consultant(Fees); Ceraclere – Consultant (1099 relationship)(Fees); Dematology Foundation – Other(Grants/Research Funding); Demira – Advisory Board(Fees); Dermavant Sciences, Inc. – Advisory Board(Fees); Eli Lilly and Company – Advisory Board(Fees); Foundation of Atopic Dermatitis – Other(Grants/Research Funding); Galderma – Advisory Board(Fees); Genentech, Inc. – Advisory Board(Honoraria); Global Parents for Eczema Research – Consultant(No Compensation Received); GpSkin – Consultant(Fees); HS Foundation – Board of Directors(No Compensation Received); Incyte – Advisory Board(Honoraria); Incyte Corporation – Advisory Board(Honoraria); LearnHealth/LearnSkin – Other(Fees), Stockholder(Stock); Menlo Therapeutics – Advisory Board(Fees); National Eczema Association – Consultant (1099 relationship)(Honoraria), Speaker(No Compensation Received); Novartis – Advisory Board(Fees); Pfizer Inc. – Advisory Board(Fees); Regeneron – Speaker(Fees); Sanofi Genzyme – Advisory Board(Fees), Speaker(Fees); Skin Actives Scientific – Other(Grants/Research Funding); Sun Pharmaceutical Industries Ltd. – Advisory Board(Fees); UCB Pharma – Advisory Board(Honoraria);
Andrea L. Zaenglein, MD, FAAD
AbbVie – Investigator(Grants/Research Funding); Arcutis Biotherapeutics – Investigator(Grants/Research Funding); Biofrontera AG – Investigator(Grants/Research Funding); Church & Dwight Co., Inc. – Consultant(Fees); Galderma Laboratories, L.P. – Investigator(Grants/Research Funding); Incyte Corporation – Investigator(Grants/Research Funding); UCB – Consultant(Honoraria);